关于移动健康干预的随机对照试验的方法挑战:跨部门调查研究和基于共识的建议
Jesus Lopez-Alcalde1,2,3, L Susan Wieland1,4, Yuqian Yan1
1Institute for Complementary and Integrative Medicine, University Hospital Zurich, Zurich, Switzerland.
Journal of medical Internet research
|December 19, 2024
概括
移动健康干预的随机对照试验面临着独特的挑战,特别是干预完整性和遵守性. 通过基于共识的建议来解决这些问题,可以提高移动健康试验结果的可靠性.
科学领域:
- 数字健康数字健康
- 临床试验 临床试验
- 医疗保健服务研究 医疗服务研究
背景情况:
- 移动健康 (mHealth) 使用移动设备进行健康支持,与传统干预不同.
- 对移动健康干预的随机对照试验 (RCT) 存在独特的方法障碍.
- 克服这些挑战对于验证mHealth对健康结果的影响至关重要.
研究的目的:
- 在mHealth RCT中确定具体的方法挑战.
- 制定基于共识的建议,以应对这些挑战.
- 提高移动健康干预研究的严谨性和可靠性.
主要方法:
- 采用了两阶段的参与式研究方法.
- 基于网络的调查评估了mHealth RCT作者所面临的挑战.
- 在线研讨会和电子邮件互动促进了关于建议的共识.
主要成果:
- 大多数mHealth RCT作者报告了重大方法上的挑战.
- 关键的挑战包括移动健康干预完整性,坚持测量和数据分析.
- 在四个类别中制定了17项基于共识的建议:依从度测量,定义,低依从率和干预组件.
结论:
- 与非mHealth试验相比,mHealth RCT 具有独特的方法挑战,特别是在干预完整性方面.
- 实施制定的建议可以导致对移动健康干预有效性的更可靠的评估.
- 这项研究为改善mHealth试验设计和执行提供了实际指导.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
Randomized Experiments
6.7K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.7K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Bias in Epidemiological Studies
153
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
153
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K


